Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

biotech

Specialty pharma company, Medexus Pharmaceuticals (MDP.TO) released fiscal Q3 2023 (quarter ended December 31st 2022) operating and financial results. The company has announced another record quarter with revenue of…
Medexus Pharmaceuticals (MDP.TO) today announced that it has reached an agreement with the provincial government of Quebec for government sponsored coverage of Cuvposa. The glycopyrrolate oral solution will be…
*originally published 01-16-23 Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company. They are not biotech. There is no research and development here. Medexus is all about sales and marketing, bringing…
Counting Sheep   For me, sleeping is both a blessing and a curse. While I love nothing more than laying in bed after a long day, I hate waking…
Kezar Life Sciences Inc. $561.261M Market Capitalization Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends…
Eye Don’t Believe It   Fill Disclosure: weekly roundups are intended to provide a quick introduction to various companies. They are not intended to be deep dives or opinion…
Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
Miraculous Microchip   Yes, you read that right. Earlier this week, German Aldana Zuniga got behind the wheel of an 850 horsepower NASCAR Cup race car. At first glance, this…
A Pain in the Behind   I don’t fear a lot of things. Well, other than spiders, heights, and being stabbed. However, more than anything I have always been afraid…
Smart Watch, Healthy Heart   There was an opportunity for a pun in the headline and I took it. In this week’s sector roundup, we are going to be…